Monitoring responses to antiangiogenic agents using noninvasive imaging tests.
Libutti
S K
SK
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Choyke
P
P
Carrasquillo
J A
JA
Bacharach
S
S
Neumann
R D
RD
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001921:Brain / Q000000981:diagnostic imaging; D003952:Diagnostic Imaging / Q000639:trends*; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging; D008279:Magnetic Resonance Imaging / Q000379:methods; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000378:metabolism*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D011859:Radiography; D013997:Time Factors; D014055:Tomography, Emission-Computed / Q000379:methods
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents